- Home
- COOK vs COEP Comparison
COOK vs COEP Comparison
Compare COOK & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COOK | COEP |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Wholesale Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.7M | 72.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | COOK | COEP |
|---|---|---|
| Price | $33.66 | $12.44 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $53.00 | N/A |
| AVG Volume (30 Days) | ★ 97.6K | 34.5K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $559,520,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $6.32 |
| 52 Week High | $35.56 | $21.41 |
Technical Indicators
Market Signals| Indicator | COOK | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 72.74 | 55.09 |
| Support Level | $0.92 | $10.65 |
| Resistance Level | $35.56 | $13.23 |
| Average True Range (ATR) | 2.54 | 0.94 |
| MACD | -0.39 | 0.18 |
| Stochastic Oscillator | 82.05 | 86.54 |
Price Performance
Historical ComparisonAbout COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.